SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001085037-22-000088
Filing Date
2022-11-30
Accepted
2022-11-29 18:44:28
Documents
8
Period of Report
2022-11-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k112922.htm 6-K 9201
2 EXHIBIT 99.1 - FINANCIAL STATEMENTS ex99_1.htm EX-99.1 554503
3 EXHIBIT 99.2 - MANAGEMENT'S DISCUSSION AND ANALYSIS ex99_2.htm EX-99.2 309358
4 EXHIBIT 99.3 - CEO CERTIFICATION ex99_3.htm EX-99.3 7672
5 EXHIBIT 99.4 - CFO CERTIFICATION ex99_4.htm EX-99.4 7649
6 EXHIBIT 99.5 - NEWS RELEASE ex99_5.htm EX-99.5 27354
7 EXHIBIT 99.6 - MATERIAL CHANGE REPORT ex99_6.htm EX-99.6 5631
8 image00001.jpg GRAPHIC 4676
  Complete submission text file 0001085037-22-000088.txt   929260
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-50112 | Film No.: 221433920
SIC: 2836 Biological Products, (No Diagnostic Substances)